Celebrating 50 Years of the TSC Alliance
The TSC Alliance will be commemorating its half-century milestone with a gala event known as 'An Evening of Progress and Promise'. This notable occasion will take place at Cipriani 42nd Street and is designed to raise funds aimed at supporting innovative research and expanding essential programs for those impacted by tuberous sclerosis complex (TSC).
History and Impact of the TSC Alliance
This organization originated in 1974, founded by four determined mothers in Southern California who aimed to improve the lives of individuals living with TSC. Today, it has evolved into a globally recognized non-profit that strives to enhance the quality of care, increase research efforts, and advocate passionately for individuals affected by TSC. It's estimated that 50,000 people in the United States and around 1 million individuals worldwide contend with this complex disorder.
A Look Ahead: The Gala's Significance
Kari Luther Rosbeck, President & CEO of TSC Alliance, shared her enthusiasm regarding the significant gala. She remarked on how it provides an opportunity not only to honor the past achievements but also to focus on future initiatives that bring hope to those affected by TSC. The community’s involvement has been vital, contributing to milestones that have improved the lives of many.
Awards to Honor Remarkable Contributions
During the gala, several distinguished individuals and groups will receive prestigious awards for their tireless work and advocacy. David and Penney Parkes will be honored with the Courage in Leadership Award for their long-standing dedication to the TSC community. Additionally, the Ramesh and Kalpana Bhatia Family Foundation will receive the TSC Champion Award, highlighting their leadership in addressing neuropsychiatric disorders associated with TSC.
Recognizing Leading Contributions to Research
The gala will also celebrate the notable achievements of the PREVeNT Trial Core Team, who will receive the Progress in Research Award. Their pioneering work has led to significant advancements in clinical trials aimed at preventing seizures in infants diagnosed with TSC. Furthermore, Derek Bauer, MD, will be awarded the Promise in Research Award for his exceptional contributions in adult neurology within TSC care.
Tuberous Sclerosis Complex: Understanding the Condition
Tuberous sclerosis complex is a rare genetic disorder resulting in tumor growth in various organs, primarily affecting the brain, heart, kidneys, skin, and lungs. The impact of TSC can severely affect an individual's quality of life, leading to significant challenges such as seizures, developmental delays, and behavioral issues. Notably, TSC stands as a leading genetic cause of epilepsy, profoundly linking it to autism as well.
About the TSC Alliance
The TSC Alliance's mission centers on enhancing the quality of life for those affected by tuberous sclerosis complex through the catalyzation of innovative treatments, ongoing research efforts, and lifelong support initiatives. They continue to push boundaries and drive change for individuals and families navigating the complexities of TSC.
Frequently Asked Questions
When and where will the TSC Alliance gala be held?
The TSC Alliance will host its gala on Friday, October 25, at Cipriani 42nd Street.
What is the purpose of the TSC Alliance gala?
The gala aims to raise funds for TSC research and to expand support programs for affected individuals and families.
Who are the key honorees at the event?
David and Penney Parkes will receive the Courage in Leadership Award, and the Ramesh and Kalpana Bhatia Family Foundation will receive the TSC Champion Award.
What is tuberous sclerosis complex?
TSC is a rare genetic disease that causes tumors to form in multiple organs, impacting functions primarily in the brain and other vital areas.
How does the TSC Alliance provide support?
The TSC Alliance supports through research efforts, advocacy, and by providing access to resources and information for affected families.
